<--- Back to Details
First PageDocument Content
Medicine / Rare diseases / Amyotrophic lateral sclerosis / Augie Nieto / Proteomics / Biomarker discovery / Biomarker / SOD1 / Muscular Dystrophy Association / Biology / Health / ALS Therapy Development Institute
Date: 2010-01-12 14:09:46
Medicine
Rare diseases
Amyotrophic lateral sclerosis
Augie Nieto
Proteomics
Biomarker discovery
Biomarker
SOD1
Muscular Dystrophy Association
Biology
Health
ALS Therapy Development Institute

Microsoft Word - applied proteomics[removed]final

Add to Reading List

Source URL: www.als.net

Download Document from Source Website

File Size: 27,47 KB

Share Document on Facebook

Similar Documents

XenTech patient-derived xenograft (PDX) panels: a clinically relevant platform for drug efficacy , target validation and predictive biomarker discovery studies. Pascal Leuraud, Stefano Cairo, Olivier Déas, Marie-France

DocID: 1uW1R - View Document

JANOUSOVA et al.: BIOMARKER DISCOVERY FOR SPARSE CLASSIFICATION OF IMAGES Annals of the BMVA Vol. 2012, No. 2, pp 1–Biomarker discovery for sparse

DocID: 1uJZI - View Document

Mass spectrometry / Chemistry / Medicine / Matrix-assisted laser desorption/ionization / Mass spectrometry imaging / Biomarker discovery / Time-of-flight mass spectrometry / Biomarker / MALDI imaging / Peptide mass fingerprinting

In cooperation with Rudolf Öhler / Gerald Stübiger Project Leaders MALDI-MS CBmed Contact:

DocID: 1qqzv - View Document

Genetic engineering / DNA / Isogenic human disease models / Oncology / Zinc finger nuclease / Cetuximab / KRAS / Non-homologous end joining / Gefitinib / Epidermal growth factor receptor / Biomarker / Phosphoinositide 3-kinase

Translating Genomes | Personalizing Medicine rAAV human gene editing, isogenic human disease models, phenotypic cellbased assays for precision functional genomics and targeted drug discovery  400 peer reviewed publica

DocID: 1pH8J - View Document

Drug discovery / Pharmacology / Pharmacy / Personalized medicine / Pharmacogenomics / Orphan drug / Clinical trial / Biomarker / Pharmacogenetics / MODDERN Cures Act / Myriad Genetics

Personalized Medicine and Companion Diagnostics: Shaping the Future of the Clinical Research Enterprise PEER REVIEWED | Heather Harris, MSc [DOI: CR]

DocID: 1p6bN - View Document